Objectives: The objective of the study was to develop new antidiabetic agents from synthetic route. Methods: An attempt was made to synthesize various flavones. The structures of the compounds were elucidated by UV, IR, 1 H-NMR and mass spectrometry. Furthermore, an in vivo antidiabetic activity study was carried out by streptozotocin induced model. Biochemical parameters were extensively studied to support anti-diabetic potential of synthesized flavones. Results: The study reveals that flavones such as F1, F2, F3, F5 and F8 were potentially considered for in-vivo antidiabetic activity. Fasting blood glucose and biochemical parameters like total protein, urea and creatinine, SGOT, SALP and SGPT were performed for the biological evaluation and compared with that of standard glibenclamide (5 mg/kg). Among the five consolidated flavones, F8 possess high significant (p < 0.01) results and restores the blood glucose level, liver enzymes and renal parameters. Based on these results, a promising potent drug would be developed in the management of diabetes mellitus. Conclusion: In-vivo evaluations of selected compounds were carried out for its antidiabetic activity considering different biochemical parameters. Some of the selected flavones showed excellent and noticeable antidiabetic activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.